Efficacy of oral tranexamic acid on blood loss in primary total hip arthroplasty using a direct anterior approach: a prospective randomized controlled trial
- 321 Downloads
Tranexamic acid (TXA), delivered intravenously or topically, has been shown to reduce blood loss, the need for transfusion, and relevant healthcare costs when administered in primary standard total hip arthroplasty (THA). Whether the same is true of oral TXA is unclear, the purpose of this study was to determine if oral tranexamic acid is equivalent to intravenous TXA in the case of patients undergoing THA via the direct anterior approach.
In this prospective randomized controlled trial, 120 patients undergoing primary THA by the direct anterior approach were randomized to receive oral TXA (two doses of 20 mg/kg), intravenous TXA (two doses of 15 mg/kg), or no TXA. Primary outcomes were haemoglobin drop, haematocrit levels, total blood loss, intra-operative blood loss, need for transfusion, and volume transfused. Secondary outcomes included thromboembolic events, wound complications, the length of post-operative hospital stay, and 30-day readmission.
Demographic characteristics were similar among the three patient groups (p > 0.05, n = 40 per group). Haemoglobin drop, haematocrit levels, total blood loss, and intra-operative blood loss were similar in the oral and intravenous groups (p > 0.05), and significantly smaller than in the control group (p < 0.05). Transfusions were given to significantly fewer patients in the oral group (3%) and intravenous group (6%) than in the control group (27%, p = 0.01). Costs of TXA and transfusions were significantly lower in the oral group than the intravenous group (p < 0.05). The three groups were similar in thromboembolic events, wound complications, the length of post-operative hospital stay, and 30-day readmission (p > 0.05).
Oral TXA shows similar efficacy and safety as intravenous TXA for reducing haemoglobin drop, haematocrit levels, total blood loss, and transfusion rate following THA by the direct anterior approach. Therefore, the much less-expensive oral formulation may be superior to the intravenous form.
KeywordsTranexamic acid Oral administration Total hip arthroplasty Direct anterior approach Blood loss
This research did not receive financial support from funding agencies in the public, commercial, or not-for-profit sectors.
- 9.Nielsen CS, Jans O, Orsnes T, Foss NB, Troelsen A, Husted H (2016) Combined intra-articular and intravenous tranexamic acid reduces blood loss in Total knee arthroplasty: a randomized, double-blind, placebo-controlled trial. J Bone Joint Surg Am 98:835–841. https://doi.org/10.2106/jbjs.15.00810 CrossRefPubMedGoogle Scholar
- 20.Kayupov E, Fillingham YA, Okroj K, Plummer DR, Moric M, Gerlinger TL, Della Valle CJ (2017) Oral and intravenous tranexamic acid are equivalent at reducing blood loss following Total hip arthroplasty: a randomized controlled trial. J Bone Joint Surg Am 99:373–378. https://doi.org/10.2106/jbjs.16.00188 CrossRefPubMedGoogle Scholar
- 23.Zhao HY, Kang PD, Xia YY, Shi XJ, Nie Y, Pei FX (2017) Comparison of early functional recovery after Total hip arthroplasty using a direct anterior or posterolateral approach: a randomized controlled trial. J Arthroplast 32:3421–3428. https://doi.org/10.1016/j.arth.2017.05.056 CrossRefGoogle Scholar
- 25.Lozano M, Basora M, Peidro L, Merino I, Segur JM, Pereira A, Salazar F, Cid J, Lozano L, Mazzara R, Macule F (2008) Effectiveness and safety of tranexamic acid administration during total knee arthroplasty. Vox Sang 95:39–44. https://doi.org/10.1111/j.1423-0410.2008.01045.x CrossRefPubMedGoogle Scholar
- 31.Zhang LK, Ma JX, Kuang MJ, Zhao J, Wang Y, Lu B, Sun L, Ma XL (2017) Comparison of oral versus intravenous application of tranexamic acid in total knee and hip arthroplasty: a systematic review and meta-analysis. Int J Surg (London, England) 45:77–84. https://doi.org/10.1016/j.ijsu.2017.07.097 CrossRefGoogle Scholar
- 34.Zohar E, Ellis M, Ifrach N, Stern A, Sapir O, Fredman B (2004) The postoperative blood-sparing efficacy of oral versus intravenous tranexamic acid after total knee replacement. Anesth Analg 99:1679–1683, table of contents. https://doi.org/10.1213/01.ane.0000136770.75805.19 CrossRefPubMedGoogle Scholar